SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-24-197025
Filing Date
2024-08-08
Accepted
2024-08-08 16:39:49
Documents
63
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d771678d10q.htm   iXBRL 10-Q 1235305
2 EX-31.1 d771678dex311.htm EX-31.1 6519
3 EX-31.2 d771678dex312.htm EX-31.2 6510
4 EX-32.1 d771678dex321.htm EX-32.1 3198
5 EX-32.2 d771678dex322.htm EX-32.2 3189
  Complete submission text file 0001193125-24-197025.txt   5402654

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vinc-20240630.xsd EX-101.SCH 33570
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vinc-20240630_cal.xml EX-101.CAL 31249
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vinc-20240630_def.xml EX-101.DEF 195972
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vinc-20240630_lab.xml EX-101.LAB 326652
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vinc-20240630_pre.xml EX-101.PRE 278105
66 EXTRACTED XBRL INSTANCE DOCUMENT d771678d10q_htm.xml XML 773454
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39244 | Film No.: 241189134
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)